SCGB2A2 and breast cancer: Additionally, hMAM-specific RT-qPCR performed for the same set of breast and ovarian cancer blood samples confirmed the tissue specific expression of mammaglobin A. Transcripts were only detected in recurrent breast cancer patients with an incidence of 38.7%, but neither in primary breast cancer patients, ovarian cancer patients, nor in the healthy controls.